ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "neutrophils"

  • Abstract Number: 1603 • ACR Convergence 2023

    Infection-Associated Antiphospholipid Antibodies and Their Potential Role in Sepsis Outcomes

    Katarina Kmetova, Emily Chong, NaveenKumar K. Somanathapura, Sherwin Navaz, Lyndsay Kluge, Srilakshmi Yalavarthi, Jason Knight, Michael Maile and Yu Zuo, University of Michigan, Ann Arbor, MI

    Background/Purpose: Antiphospholipid syndrome (APS) is an acquired autoimmune thrombophilia characterized by circulating antiphospholipid antibodies (aPL). While the association between aPL and infection has long been…
  • Abstract Number: 0050 • ACR Convergence 2023

    Anti-Citrullinated Histone Antibody CIT-013, a Dual Action Therapeutic for Neutrophil Extracellular Trap Associated Autoimmune Disease

    Maarten van der Linden1, Sangeeta Kumari1, Daphne Montizaan1, Stephanie van Dalen1, Annemarie Kip1, Martyn FOSTER2, Inge Reinieren1, Elsa Neubert3, Luise Erpenbeck4, Tirza Bruurmijn1, Peter van Zandvoort1, Paul Vink1, Eric Meldrum5, Helmuth van Es1 and Renato Chirivi1, 1Citryll BV, Oss, Netherlands, 2Experimental Pathology Consultancy, Benfleet, United Kingdom, 3Leiden Academic Centre for Drug Research, Leiden, Netherlands, 4University Medical Center Münster, General Dermatology and Venereology, Münster, Germany, 5Citryll BV, Basel, Switzerland

    Background/Purpose: Neutrophil extracellular traps (NETs) contribute to the pathophysiology of multiple inflammatory and autoimmune diseases (Chirivi et al., 2021; DOI: 10.1038/s41423-020-0381-3). Targeting the NETosis pathway…
  • Abstract Number: 1705 • ACR Convergence 2023

    Reduced DNASE1L3 Activity and Increased Anti-NET Protective Antibodies Contributes to Accumulation of Neutrophil Extracellular Traps in Pediatric SLE Patients

    Betsy Barnes1, Lydia Thomas2, Jenna Battaglia Battaglia3, Kim Simpfendorfer3, Joyce Hui-Yuen4, Vinay Sharma5 and Bharati Matta6, 1Northwell Health, Manhasset, NY, 2Northwell Health - Cohen Children's Medical Center, Lake Success, NY, 3Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, 4North Shore LIJ Health System, Great Neck, NY, 5Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India, 6The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY and Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, NY

    Background/Purpose: Pediatric systemic lupus erythematosus (pSLE) is a multisystemic chronic autoimmune disease with high renal involvement. In SLE, neutrophil extracellular traps (NETs) are considered a…
  • Abstract Number: 0060 • ACR Convergence 2023

    Serpin B1 Modulation of Immune Complex-Mediated Neutrophil Activation and NET-formation Requires Its Chymotrypsin-like Inhibitory Activity

    Ting Wang1, Philip Pemberton2 and Christian Lood1, 1University of Washington, Seattle, WA, 2Redd Pharmaceuticals, Belmont, CA

    Background/Purpose: Autoantibody-antigen complex-driven formation of neutrophil extracellular traps (NETs) is a major contributing factor to the pathophysiology and clinical manifestations of many different autoimmune diseases…
  • Abstract Number: 1735 • ACR Convergence 2023

    An Unorthodox HLA-DRhiCD15+ ‘Hybrid’ Population in Rheumatoid Arthritis Characterized Using Spectral Cytometry

    Christian Geier1, Haani Qudsi2, Jihad BenGabr1, Robert Winchester3 and Andras Perl4, 1SUNY Upstate Medical University, Syracuse, NY, 2Norton College of Medicine, SUNY Upstate Medical University, Syracuse, NY, 3Columbia University, New York, NY, 4SUNY, Syracuse, NY

    Background/Purpose: A variant of HLA-DR confers the strongest genetic risk for rheumatoid arthritis (RA) suggesting that DRhi cells are important in RA. We previously found…
  • Abstract Number: 0101 • ACR Convergence 2023

    Non-Criteria Antiphospholipid Antibodies and Calprotectin as Potential Biomarkers in Pediatric Antiphospholipid Syndrome

    Elizabeth Sloan1, Katarina Kmetova2, NaveenKumar K. Somanathapura2, Lyndsay Kluge2, Emily Chong2, Claire Hoy2, Srilakshmi Yalavarthi2, Jacqueline Madison2, Cyrus Sarosh2, Lynnette Walters3, Jeanine Baisch4, Jessica Turnier2, Virginia Pascual4, Tracey Wright1, Jason Knight2, Ayesha Zia1 and Yu Zuo2, 1UT Southwestern, Dallas, TX, 2University of Michigan, Ann Arbor, MI, 3Scottish Rite Hospital for Children, Dallas, TX, 4Weill Cornell Medicine, New York, NY

    Background/Purpose: While classification criteria for pediatric APS are not yet available, recent research suggests pediatric APS patients are unique, and many present with extra-criteria manifestations…
  • Abstract Number: 1765 • ACR Convergence 2023

    Persistent Cigarette Smoking Is Associated with Rheumatoid Arthritis Onset and Neutrophil Activation in a Prospective Study of At-risk First-Degree Relatives

    Jeba Maisha, Xiaobo Meng, Hani El-Gabalawy and Liam O'Neil, University of Manitoba, Winnipeg, MB, Canada

    Background/Purpose: Cigarette smoking (CS) is a major environmental risk factor for the development of Rheumatoid Arthritis (RA), and is associated with the development of RA…
  • Abstract Number: 0110 • ACR Convergence 2023

    Neutrophil Extracellular Traps as Mediators of Antiphospholipid Antibody-Induced Trophoblast Dysfunction and Fetal Loss

    Christine Rysenga, Srilakshmi Yalavarthi, Wenying Liang, Claire Hoy, Cyrus Sarosh, Richard Lieberman, Yu Zuo and Jason Knight, University of Michigan, Ann Arbor, MI

    Background/Purpose: Antiphospholipid antibodies (aPL) induce obstetric complications associated with placental insufficiency by promoting trophoblast dysfunction and inflammation at the maternal-fetal interface. Neutrophils have been found…
  • Abstract Number: 1776 • ACR Convergence 2023

    Macrophage Migration Inhibitory Factor May Help Maintain Tight Junctions in the Gut by Enhancing Occludin Expression

    Shaghayegh Foroozan1 and Nigil Haroon2, 1University Health Network/University of Toronto, Toronto, ON, Canada, 2University of Toronto, University Health Network, Schroeder Arthritis Institute, Department of Medicine/Rheumatology, Toronto, ON, Canada

    Background/Purpose: Axial Spondyloarthritis (AxSpA) is a chronic inflammatory disease with multifactorial origins, primarily affecting the musculoskeletal system. Gut inflammation is seen in the majority of…
  • Abstract Number: 0112 • ACR Convergence 2023

    Molecular Stratification of Antiphospholipid Syndrome Patients Through Integrative Analysis of the Whole-blood RNA Transcriptome

    Amala Ambati1, Feiyang Ma1, Katarina Kmetova1, Sherwin Navaz1, Claire Hoy1, Cyrus Sarosh1, Ajay Tambralli1, Johann E. Gudjonsson1, J. Michelle Kahlenberg1, Jacqueline Madison1, Ali Duarte-Garcia2, Jason Knight1 and Yu Zuo1, 1University of Michigan, Ann Arbor, MI, 2Mayo Clinic, Rochester, MN

    Background/Purpose: Antiphospholipid syndrome (APS) is an acquired thrombo-inflammatory disease associated with diverse clinical manifestations in the setting of persistent antiphospholipid antibodies (aPL). Early diagnosis and…
  • Abstract Number: 1781 • ACR Convergence 2023

    TNF Induces Neutrophil Elastase/Gasdermin D-mediated Neutrophil Extracellular Traps in Axial Spondyloarthritis

    Yehao Li and Xiang Peng, Department of Rheumatology and Immunology, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, Qingyuan, China

    Background/Purpose: Emerging studies have shown that neutrophil extracellular traps (NETs) are increased and associated with the disease activity in patients with axial spondyloarthritis (axSpA). However,…
  • Abstract Number: 0113 • ACR Convergence 2023

    Serum Myeloperoxidase (MPO)-DNA Complexes and Serum Calprotectin Differentiate Isolated Thrombotic Antiphospholipid Syndrome from Isolated Obstetric Antiphospholipid Syndrome

    Ruyu Liang1, Ranran Yao2, Ziye Wang3, Wenwen Pei2, Renge Liang3 and Chun Li4, 1Peking University, XiCheng, China, 2Peking University, Beijing, China, 3Peking University People's Hospital, Beijing, China, 4Peking University People’s Hospital, Beijing, China

    Background/Purpose: There is a lack of serum markers to differentiate thrombotic APS (tAPS) and obstetric APS (oAPS). Neutrophil extracellular traps (NETs) are involved in the…
  • Abstract Number: 2189 • ACR Convergence 2023

    Lymphopenia Fluctuation Patterns Determine the Trajectory of the Disease in Sjogren’s Patients with Hematological Involvement

    Giovanni Fulvio1, Matilde Bandeira2, Augusto Silva3, Gaetano La Rocca4, Silvia Fonzetti5, Francesco Ferro6, Marta Mosca7, Vasco Romão2, Chiara Baldini1, Manuel Silvério-António8 and Nikita Khmelinskii2, 1University of Pisa, Pisa, Italy, 2Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal, 3Santa Maria Hospital, Maceira, Portugal, 4University of Pisa, Rheumatology Unit, Pisa, Italy, 5AOUP, Pisa, Italy, 6Clinical and Experimental Medicine Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy, 7Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 8Hospital Santa Maria, Lisboa, Portugal

    Background/Purpose: Sjogren's disease (SjD) is characterized by a moderate prevalence of cytopenia, mainly neutropenia and lymphocytopenia with a typical fluctuating pattern. The associations between clinical…
  • Abstract Number: 0259 • ACR Convergence 2023

    Preliminary Experience with a Novel “Fix” for Deep Epitope and Transcriptional Phenotyping of Fragile Cells from Autoinflammatory Flares

    Hallie Carol1, Emily Landy2 and Scott Canna1, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Autoinflammatory diseases (AID) are characterized by inflammation and immunopathology due to primary defects in the innate immune response. Neutrophils (PMN) feature prominently in the…
  • Abstract Number: 2233 • ACR Convergence 2023

    Neutrophil Levels Associate with Early Improvement in Spinal Pain and Week 24 Multi-Domain Disease Control During Guselkumab Treatment in Active Psoriatic Arthritis: Post Hoc Pooled Analyses of Two Phase 3 Randomized Controlled Trials

    Thomas Macleod1, Xenofon Baraliakos2, Emmanouil Rampakakis3, Warner Chen4, Antonius Pieter J Van Den Heuvel4, Loqmane Seridi4, May Shawi5, Frederic Lavie6, Joseph F. Merola7, Proton Rahman8 and Dennis McGonagle9, 1University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom, 2Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 3McGill University, Department of Pediatrics / JSS Medical Research, Scientific Affairs, Montreal, QC, Canada, 4Translational Sciences, Janssen Research & Development, LLC, Spring House, PA, 5Immunology, Janssen Research & Development, LLC, Titusville, NJ, 6The Janssen Pharmaceutical Companies of Johnson & Johnson, Paris, France, 7Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 8Craig Dobbin Research Institute, Memorial University, St. John's, NL, Canada, 9Leeds Biomedical Research Centre, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Neutrophils have potential pathogenic roles in chronic inflammatory diseases (e.g., neutrophilic cutaneous microabscesses in psoriasis, and neutrophils in the synovial fluid/tissue in PsA and…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology